Savara
SVRA
#6091
Rank
NZ$1.75 B
Marketcap
NZ$8.58
Share price
-0.79%
Change (1 day)
165.27%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Savara's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$0.21 Billion23.94%
2024 -NZ$0.17 Billion75.29%
2023 -NZ$93.54 Million43.38%
2022 -NZ$65.25 Million-11.31%
2021 -NZ$73.56 Million-13.3%
2020 -NZ$84.85 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.12 Billion105.54%
2017 -NZ$57.18 Million34.11%
2016 -NZ$42.64 Million-37.43%
2015 -NZ$68.14 Million38.81%
2014 -NZ$49.09 Million33.62%
2013 -NZ$36.74 Million38.49%
2012 -NZ$26.53 Million24.59%
2011 -NZ$21.29 Million-36.5%
2010 -NZ$33.53 Million-3.14%
2009 -NZ$34.62 Million-23.28%
2008 -NZ$45.12 Million8.52%
2007 -NZ$41.58 Million-34.14%
2006 -NZ$63.13 Million184.43%
2005 -NZ$22.2 Million90.75%
2004 -NZ$11.64 Million190.35%
2003 -NZ$4.01 Million11.64%
2002 -NZ$3.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion 34.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.05 Million-84.72%๐Ÿ‡บ๐Ÿ‡ธ USA